After eight months of systemic treatment, the patient was stable and underwent left adrenalectomy, with final pathology confirming an extra-renal (adrenal) TFE3 translocation-associated RCC (MiT family translocation RCC). The gene discussed is TFE3; the disease is renal cell carcinoma.